Ftdtl - opiates DRI reagent
Ended Awarded Last action
- Contract number
- W91YTZ24F0019
- Awardee
-
Microgenics Corporation UEI E7WGWEK19Y79 Part of Thermo Electron Corporation
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $2,712
Award facts
- Contract value 100% obligated
- $2,711.60 Current and potential, with all options
- Completion date
- Current and potential, with all options
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Fort Meade, MD 20755, USA
Award details come from SAM.gov/FPDS.
About this award
Microgenics Corporation, a clinical diagnostics subsidiary of Thermo Electron Corporation, was awarded a delivery order valued at $2,711.60 by the Defense Health Agency on December 8, 2023, for FTDTL Opiates DRI Reagent kits to be delivered to Fort Meade, Maryland. This firm fixed-price delivery order carries no set-aside designation, reflecting Microgenics' established competitive position in the federal marketplace for diagnostic reagents. The contract supports the Department of Defense Drug Demand Reduction Program by supplying specialized immunoassay reagent test kits designed for opiate detection in substance abuse testing and medical screening applications across military healthcare systems.
This delivery order is placed under Microgenics' larger indefinite delivery contract framework for DRI Opiate reagent kits, valued at $750,435.30, which was previously established with the Defense Health Agency to provide ongoing access to critical diagnostic reagents. Microgenics has demonstrated sustained capability in this area through multiple federal contracts supplying a comprehensive range of toxicology testing solutions, including kits for detecting opiates, benzodiazepines, amphetamines, and other controlled substances. The company's portfolio of single-award IDVs with the Navy Bureau of Medicine and Surgery, Defense Health Agency, and Veterans Affairs agencies underscores its strategic importance in supporting substance abuse testing across Department of Defense and veteran healthcare operations.
Quick answers
Who was awarded contract W91YTZ24F0019?
W91YTZ24F0019 was awarded to Microgenics Corporation by Medical Command (Department of the Army) on December 8, 2023.
How much is contract W91YTZ24F0019 worth?
The government has obligated $2,712 on W91YTZ24F0019.
Which agency awarded contract W91YTZ24F0019?
Medical Command (Department of the Army) awarded W91YTZ24F0019, with funding from Defense Health Agency (Department of Defense).
Is contract W91YTZ24F0019 an order under another contract?
Yes. W91YTZ24F0019 is a delivery order under N6264523D5006, an indefinite delivery contract.
Was contract W91YTZ24F0019 competed?
The extent of competition for W91YTZ24F0019 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award